• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2014 - 2019年华南男男性行为者抗逆转录病毒治疗失败人群中的HIV-1耐药性与基因传播网络

HIV-1 Drug Resistance and Genetic Transmission Networks Among MSM Failing Antiretroviral Therapy in South China 2014-2019.

作者信息

Lan Yun, Deng Xizi, Li Linghua, Cai Weiping, Li Junbin, Cai Xiaoli, Li Feng, Hu Fengyu, Lei Chunliang, Tang Xiaoping

机构信息

Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, 510030, People's Republic of China.

出版信息

Infect Drug Resist. 2021 Aug 4;14:2977-2989. doi: 10.2147/IDR.S317187. eCollection 2021.

DOI:10.2147/IDR.S317187
PMID:34377002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8349545/
Abstract

BACKGROUND

Guangdong, located in South China, is one of the areas heavily affected by HIV-1 in China. The transmission of HIV-1 among men who have sex with men (MSM) has gradually been increasing in Guangdong.

OBJECTIVE

To investigate the characteristics of the HIV-1 drug resistance, and genetic transmission networks in MSM with antiretroviral therapy (ART) failure from 2014 to 2019 in Guangdong.

METHODS

HIV-1 gene sequences were amplified. An online subtyping tool was used to determine the genotype, and a maximum likelihood phylogenetic tree was reconstructed to confirm the genotype results. The Stanford University HIV Drug Resistance Database was used to analyse the sequences of drug resistance mutations (DRMs) and drug resistance profiles. A pairwise Tamura-Nei 93 genetic distance-based method was used to analyse the genetic transmission networks.

RESULTS

Of 393 sequences isolated from HIV-infected MSM with ART failure, CRF01_AE (47.3%), CRF07_BC (21.4%) and CRF55_01B (21.4%) were the top three strains. 55.2% individuals harboured NRTI DRMs, whereas 67.4% carried NNRTI DRMs. 96.8% cases harboured mutations resistance to NRTIs or NNRTIs at high-level. The most common DRMs were M184I/V (42.2%), followed by V179D/E (37.9%) and K65R (27.2%). Of the subtype B sequences, no sequence fell into a cluster. Of the CRF01_AE, CRF55_01B, and CRF59_01B sequences, 14.5%, 61.9%, and 33.3% fell into clusters, respectively. Of the CRF07_BC sequences, 39.3% fell into clusters. The majority of MSM in transmission networks were concentrated at age below 35 years old, with multiple links. Moreover, approximately 54.8% of MSM had more than 2 potential transmission partners.

CONCLUSION

Drug resistance mutations more frequently occurred in NNRTIs among MSM with ART failure in Guangdong Province. Transmission network analysis revealed a complex transmission pattern, and more attention should be given to younger HIV-1-infected MSM with multiple links.

摘要

背景

广东位于中国南部,是中国受HIV-1严重影响的地区之一。在广东,男男性行为者(MSM)中HIV-1的传播呈逐渐上升趋势。

目的

调查2014年至2019年广东接受抗逆转录病毒治疗(ART)失败的MSM中HIV-1耐药特征及基因传播网络。

方法

扩增HIV-1基因序列。使用在线分型工具确定基因型,并重建最大似然系统发育树以确认基因型结果。利用斯坦福大学HIV耐药数据库分析耐药突变(DRM)序列和耐药谱。采用基于Tamura-Nei 93双参数遗传距离的方法分析基因传播网络。

结果

在从接受ART治疗失败的HIV感染MSM中分离出的393个序列中,CRF01_AE(47.3%)、CRF07_BC(21.4%)和CRF55_01B(21.4%)是前三大毒株。55.2%的个体携带核苷类逆转录酶抑制剂(NRTI)DRM,而67.4%携带非核苷类逆转录酶抑制剂(NNRTI)DRM。96.8%的病例携带对NRTIs或NNRTIs高水平耐药的突变。最常见的DRM是M184I/V(42.2%),其次是V179D/E(37.9%)和K65R(27.2%)。在B亚型序列中,没有序列聚为一簇。在CRF01_AE、CRF55_01B和CRF59_01B序列中,分别有14.5%、61.9%和33.3%聚为一簇。在CRF07_BC序列中,39.3%聚为一簇。传播网络中的大多数MSM集中在35岁以下,且存在多个联系。此外,约54.8%的MSM有超过2个潜在传播伙伴。

结论

在广东省接受ART治疗失败的MSM中,NNRTIs耐药突变更频繁发生。传播网络分析揭示了复杂的传播模式,应更加关注有多个联系的年轻HIV-1感染MSM。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a59/8349545/fea8169f30be/IDR-14-2977-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a59/8349545/22c40d34af0e/IDR-14-2977-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a59/8349545/fea8169f30be/IDR-14-2977-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a59/8349545/22c40d34af0e/IDR-14-2977-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a59/8349545/fea8169f30be/IDR-14-2977-g0002.jpg

相似文献

1
HIV-1 Drug Resistance and Genetic Transmission Networks Among MSM Failing Antiretroviral Therapy in South China 2014-2019.2014 - 2019年华南男男性行为者抗逆转录病毒治疗失败人群中的HIV-1耐药性与基因传播网络
Infect Drug Resist. 2021 Aug 4;14:2977-2989. doi: 10.2147/IDR.S317187. eCollection 2021.
2
HIV-1 subtype diversity, drug resistance, and genetic transmission networks in men who have sex with men with virologic failure in antiretroviral therapy in Sichuan, China, 2011 to 2017.2011年至2017年中国四川接受抗逆转录病毒治疗但病毒学治疗失败的男男性行为者中的HIV-1亚型多样性、耐药性及基因传播网络
Medicine (Baltimore). 2019 Oct;98(43):e17585. doi: 10.1097/MD.0000000000017585.
3
Drug resistance and genetic transmission characteristics of HIV-1 CRF59_01B in infected patients in Guangdong Province, China.中国广东省感染患者中 HIV-1 CRF59_01B 的耐药性和遗传传播特征。
J Antimicrob Chemother. 2022 Jun 29;77(7):1960-1968. doi: 10.1093/jac/dkac132.
4
HIV-1 genetic transmission networks among men who have sex with men in Kunming, China.中国昆明男男性行为人群中 HIV-1 的基因传播网络。
PLoS One. 2018 Apr 26;13(4):e0196548. doi: 10.1371/journal.pone.0196548. eCollection 2018.
5
Characteristics of HIV-1 molecular transmission networks and drug resistance among men who have sex with men in Tianjin, China (2014-2018).中国天津男男性行为人群中 HIV-1 分子传播网络特征及耐药情况(2014-2018 年)。
Virol J. 2020 Nov 3;17(1):169. doi: 10.1186/s12985-020-01441-8.
6
Characteristics of drug resistance in HIV-1 CRF55_01B from ART-experienced patients in Guangdong, China.中国广东地区接受过 ART 治疗的患者中 HIV-1 CRF55_01B 的耐药特征。
J Antimicrob Chemother. 2020 Jul 1;75(7):1925-1931. doi: 10.1093/jac/dkaa116.
7
Prevalence of Drug Resistance and Genetic Transmission Networks Among Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Patients with Antiretroviral Therapy Failure in Guangxi, China.中国广西地区抗逆转录病毒治疗失败的艾滋病病毒/获得性免疫缺陷综合征患者的耐药性和遗传传播网络的流行情况。
AIDS Res Hum Retroviruses. 2022 Oct;38(10):822-830. doi: 10.1089/AID.2021.0181. Epub 2022 Oct 5.
8
Genetic characterization of HIV-1 epidemic in Anhui Province, China.中国安徽省 HIV-1 流行的遗传特征。
Virol J. 2020 Feb 3;17(1):17. doi: 10.1186/s12985-020-1281-y.
9
Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study.中国广东地区未经治疗的 HIV-1 患者中的传播耐药和传播簇:一项横断面研究。
Virol J. 2021 Sep 6;18(1):181. doi: 10.1186/s12985-021-01653-6.
10
HIV-1 drug resistance and genetic transmission network among newly diagnosed people living with HIV/AIDS in Ningbo, China between 2018 and 2021.2018 年至 2021 年期间中国宁波新诊断的艾滋病毒感染者/艾滋病患者中 HIV-1 耐药性和遗传传播网络。
Virol J. 2023 Oct 13;20(1):233. doi: 10.1186/s12985-023-02193-x.

引用本文的文献

1
The origin and dissemination of HIV-1 subtype B on Hainan Island, South China, 2007-2024.2007 - 2024年中国南方海南岛HIV-1 B亚型的起源与传播
BMC Infect Dis. 2025 Mar 4;25(1):310. doi: 10.1186/s12879-025-10703-1.
2
Molecular network analysis for detecting HIV transmission clusters: insights and implications.用于检测HIV传播集群的分子网络分析:见解与启示
Front Public Health. 2025 Jan 29;13:1429464. doi: 10.3389/fpubh.2025.1429464. eCollection 2025.
3
Transmitted drug resistance and molecular transmission network among treatment-naive HIV-1 patients in Wenzhou, China, 2020-2023.

本文引用的文献

1
Complicated genotypes circulating among treatment naïve HIV-1 patients in Guangzhou, China.中国广州未经治疗的 HIV-1 患者中流行的复杂基因型。
Infect Genet Evol. 2021 Jan;87:104673. doi: 10.1016/j.meegid.2020.104673. Epub 2020 Dec 9.
2
First Assessment of Acquired HIV-1 Drug Resistance and Mutation Patterns in Suriname.苏里南获得性 HIV-1 耐药性和突变模式的首次评估。
AIDS Res Hum Retroviruses. 2021 Jul;37(7):557-565. doi: 10.1089/AID.2020.0194. Epub 2021 Jan 12.
3
Addressing advanced HIV disease and mortality in global HIV programming.
2020-2023 年中国温州未经治疗的 HIV-1 患者中的传播耐药性和分子传播网络。
Virol J. 2024 Oct 17;21(1):257. doi: 10.1186/s12985-024-02528-2.
4
A systematic review and meta-analysis of HIV transmission risk behaviors, genetic variations, and antiretroviral (ARV) resistance in LGBT populations.对 LGBT 人群中 HIV 传播风险行为、基因变异和抗逆转录病毒(ARV)耐药性的系统评价与荟萃分析。
J Public Health Res. 2024 Apr 14;13(2):22799036241239464. doi: 10.1177/22799036241239464. eCollection 2024 Apr.
5
Retrospective Study on Genetic Diversity and Drug Resistance among People Living with HIV at an AIDS Clinic in Beijing.北京某艾滋病诊所艾滋病毒感染者的基因多样性与耐药性回顾性研究
Pharmaceuticals (Basel). 2024 Jan 16;17(1):115. doi: 10.3390/ph17010115.
6
Presence of the M184I mutation after short-term exposure to azvudine for COVID-19 in people living with HIV.艾滋病毒感染者短期服用阿兹夫定治疗新冠肺炎后出现M184I突变。
AIDS. 2023 Jul 1;37(8):1341-1342. doi: 10.1097/QAD.0000000000003564.
7
Drug Resistance Profile Among HIV-1 Infections Experiencing ART with Low-Level Viral Load in Guangdong China During 2011-2022: A Retrospective Study.2011 - 2022年中国广东低病毒载量接受抗逆转录病毒治疗的HIV-1感染患者的耐药情况:一项回顾性研究
Infect Drug Resist. 2023 Jul 31;16:4953-4964. doi: 10.2147/IDR.S419610. eCollection 2023.
8
Transmission and Drug Resistance Characteristics of Human Immunodeficiency Virus-1 Strain Using Medical Information Data Retrieval System.利用医学信息数据检索系统研究人类免疫缺陷病毒-1 株的传播和耐药特征。
Comput Math Methods Med. 2022 Jun 13;2022:2173339. doi: 10.1155/2022/2173339. eCollection 2022.
9
Biophysical Characterization of Novel DNA Aptamers against K103N/Y181C Double Mutant HIV-1 Reverse Transcriptase.新型 DNA 适体对 K103N/Y181C 双突变 HIV-1 逆转录酶的生物物理特性分析。
Molecules. 2022 Jan 3;27(1):285. doi: 10.3390/molecules27010285.
在全球艾滋病规划中应对晚期艾滋病疾病和死亡率问题。
AIDS Res Ther. 2020 Jul 10;17(1):40. doi: 10.1186/s12981-020-00296-x.
4
Genetic Diversity and Drug Resistance of HIV-1 CRF55_01B in Guangdong, China.中国广东 HIV-1 CRF55_01B 的遗传多样性和耐药性。
Curr HIV Res. 2020;18(3):210-218. doi: 10.2174/1570162X18666200415140652.
5
Prevalence of acquired drug resistance mutations in antiretroviral- experiencing subjects from 2012 to 2017 in Hunan Province of central South China.2012 年至 2017 年中国中南地区湖南省接受抗逆转录病毒治疗的患者中获得性耐药突变的流行情况。
Virol J. 2020 Mar 17;17(1):38. doi: 10.1186/s12985-020-01311-3.
6
Genetic characterization of HIV-1 epidemic in Anhui Province, China.中国安徽省 HIV-1 流行的遗传特征。
Virol J. 2020 Feb 3;17(1):17. doi: 10.1186/s12985-020-1281-y.
7
Trend of HIV-1 drug resistance in China: A systematic review and meta-analysis of data accumulated over 17 years (2001-2017).中国HIV-1耐药性趋势:对17年(2001 - 2017年)积累数据的系统评价和荟萃分析
EClinicalMedicine. 2020 Jan 5;18:100238. doi: 10.1016/j.eclinm.2019.100238. eCollection 2020 Jan.
8
HIV-1 subtype diversity, drug resistance, and genetic transmission networks in men who have sex with men with virologic failure in antiretroviral therapy in Sichuan, China, 2011 to 2017.2011年至2017年中国四川接受抗逆转录病毒治疗但病毒学治疗失败的男男性行为者中的HIV-1亚型多样性、耐药性及基因传播网络
Medicine (Baltimore). 2019 Oct;98(43):e17585. doi: 10.1097/MD.0000000000017585.
9
Prevalence of pretreatment and acquired HIV-1 mutations associated with resistance to lamivudine or rilpivirine: a systematic review.与拉米夫定或rilpivirine耐药相关的治疗前和获得性HIV-1突变的流行率:一项系统评价。
Antivir Ther. 2019;24(6):393-404. doi: 10.3851/IMP3331.
10
Rates of HIV-1 virological suppression and patterns of acquired drug resistance among fisherfolk on first-line antiretroviral therapy in Uganda.乌干达一线抗逆转录病毒治疗中渔民的 HIV-1 病毒学抑制率和获得性耐药模式。
J Antimicrob Chemother. 2019 Oct 1;74(10):3021-3029. doi: 10.1093/jac/dkz261.